Founder resource
Life Sciences Insurance Requirements by Funding Stage
Insurance requirements for a life sciences company rarely arrive on a schedule. They arrive with events: a term sheet, a hospital pilot, a first hire, an FDA milestone, a distribution agreement. Each event tends to introduce a new coverage or raise the bar on one already in place.
This reference maps the coverages that most commonly become relevant at each funding stage, and the trigger that usually drives them. It is general guidance rather than a mandate. The right program depends on the specific company, its segment, and the contracts it signs, so treat this as a way to anticipate what is coming rather than a checklist that fits every company.
The reference
What tends to arrive at each stage.
Stage 01
Pre-Seed and Formation
Trigger: Incorporation, first hires, early IP and data.
Coverage that commonly becomes relevant
- Business owners or general liability, once there is a lease, equipment, or people
- Basic cyber, once the company holds any sensitive data
Coverage is usually light at this stage. The main goal is a clean foundation, not a full program.
Stage 02
Seed
Trigger: First priced round, an outside board seat, early clinical or product data.
Coverage that commonly becomes relevant
- Directors and officers, often a condition of the financing
- Cyber, and technology errors and omissions if the product is software
- General liability as operations grow
Directors and officers coverage commonly appears here for the first time, driven by the investor rather than by revenue.
Stage 03
Series A
Trigger: Institutional lead investor, scaling headcount, clinical studies underway.
Coverage that commonly becomes relevant
- Directors and officers at higher limits, per the financing terms
- Employment practices liability as the team grows
- Clinical trials liability before any study site activates
- Product liability planning as commercialization approaches
Employment practices exposure rises with headcount, and study sites will not activate without evidence of trial coverage.
Stage 04
Series B and Commercial Preparation
Trigger: FDA milestones, hospital pilots, manufacturing build-out, larger team.
Coverage that commonly becomes relevant
- Products liability as the device or product nears market
- Cyber and HIPAA where protected health information is involved
- Property and equipment for facilities and manufacturing
- Directors and officers scaling with the round
This is the stage where a program built for a development company often stops fitting the company it has become.
Stage 05
Commercial and Revenue
Trigger: First sales, hospital and distributor contracts, product in the field.
Coverage that commonly becomes relevant
- Products liability as the central coverage
- Product recall coverage, which products liability does not include
- Contract-required limits and additional insured status
- Workers compensation, and cyber tuned to the live operation
Customer contracts now dictate much of the program. Reading the insurance schedule before signing is where a company keeps its leverage.
Stage 06
Established, Scale, and Exit
Trigger: International expansion, larger contracts, mergers and acquisitions.
Coverage that commonly becomes relevant
- A full program reviewed against current footprint and contracts
- International extensions where the company operates abroad
- Umbrella or excess liability over the primary layers
- Run-off or tail coverage for directors and officers at an exit
At an acquisition, directors usually need run-off coverage so they remain protected for decisions made before the sale.
Take it with you
Get the reference as a printable PDF.
A clean, printable reference you can share with a co-founder, a CFO, or your board ahead of a round. No sales follow-up unless you ask for it.
Common questions
Frequently Asked Questions
When Does A Life Sciences Startup Need Its First Insurance?
Usually earlier than founders expect, and driven by an event rather than a revenue number. The first priced financing often requires directors and officers coverage, a clinical study requires trial coverage before a site activates, and a first hire introduces employment exposure. The trigger is the event, not the stage.
What Insurance Do Investors Typically Require?
Directors and officers coverage is the most common, often written into the financing documents as a closing condition with a specified minimum limit. It is worth reading that language before the round closes rather than after.
What Changes At Commercialization?
Products liability becomes central, recall exposure becomes real for the first time, and customer contracts begin dictating limits and additional insured status. A program built for a pre-revenue company generally does not contemplate any of this, so it should be rebuilt rather than renewed unchanged.
Does This Reference Replace A Coverage Review?
No. It is a way to anticipate what tends to arrive at each stage. The right program depends on the specific company, its segment, and its contracts, which is what a coverage review works through.
Coverage review
Not sure what your stage actually requires?
Start a coverage review and we'll map your specific situation against the coverages above, then respond within one business day with a clear next step.